Back

Percutaneous treatment of pulmonary thromboembolism: clinical presentation and hemodynamic results in usual clinical practice

3 March 2019 (11:30 - 11:45)
Organised by:
Congress Presentation Part of: Young Investigator Awards Abstracts Intervention ACVC Premium Access Acute Cardiovascular Care 2019

About the speaker

Photo
Doctor Maria Isabel Barrionuevo Sanchez

University Hospital of Bellvitge, Barcelona (Spain)

4 More presentations in this session

Presentation thumbnail
Predictors of contrast-induced nephropathy in patients with acute coronary syndrome undergoing cardiac catheterization
Doctor I. Campos (Braga, PT)
Abstract Slides Video
Presentation thumbnail
The biomarker mid-regional pro-adrenomedullin drawn upon admission for ST-elevation myocardial infarction is a strong predictor of 30-day mortality
Doctor S. Wiberg (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Hemodynamic status during targeted temperature management and association with cerebral and cardiovascular death after out-of-hospital cardiac arrest.
Doctor J. Grand (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Impact of accompanying dyspnea on diagnosis and outcome of patients with suspected acute coronary syndrome
Doctor J. Boeddinghaus (Basel, CH)
Abstract

Access the full session

Session thumbnail
Young Investigator Awards Abstracts

The Event

Event poster

Acute Cardiovascular Care 2019

3 March 2019 11:30 CET
You may be interested in
thumbnail
Congress Presentation
Endovascular treatment of pulmonary embolism: experience from a tertiary center
20 March 2026
thumbnail
Webinar
Percutaneous therapies for acute pulmonary embolism: state-of-the-art
30 May 2023
thumbnail
Congress Presentation
Clinical and management differences in patients with active cancer and pulmonary embolism
20 June 2025
thumbnail
Congress Presentation
Pulmonary embolism, free-floating thrombus and thrombocytopenia
3 March 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources